Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Opal

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Annals of Internal Medicine|October 2, 2002
Bioterrorism and physiciansAndrew W Artenstein, Marguerite A Neill, Steven M Opal
Innate Immunity|November 10, 2018
Whatever happened to the Shwartzman phenomenon?Abdullah B Chahin, Jason M Opal, Steven M Opal
Critical Care Medicine|May 11, 2002
Antithrombin, heparin, and heparan sulfateSteven M Opal, Craig M Kessler, Juergen Roemisch, et al.
Plos One|February 18, 2016
Isolating Influenza RNA from Clinical Samples Using Microfluidic Oil-Water InterfacesFrancis R Cui, Jingjing Wang, Steven M Opal, et al.
Critical Care Medicine|March 11, 2003
Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemiaSteven M Opal, John E Palardy, Nicolas Parejo, et al.
Critical Care Medicine|April 24, 2008
Sepsis: time to reconsider the conceptJean Carlet, Jonathan Cohen, Thierry Calandra, et al.
Mbio|February 25, 2016
Reply to "Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?"David S Fedson, Jeffrey R Jacobson, Ole Martin Rordam, et al.
Lancet (London, England)|March 12, 2013
Sepsis definitions: time for changeJean-Louis Vincent, Steven M Opal, John C Marshall, et al.
Mbio|June 25, 2015
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor BlockersDavid S Fedson, Jeffrey R Jacobson, Ole Martin Rordam, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|October 7, 2014
Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodiesThomas T DeLeon, Heath H Chung, Steven M Opal, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Annals of Internal Medicine|October 2, 2002
Bioterrorism and physiciansAndrew W Artenstein, Marguerite A Neill, Steven M Opal
Innate Immunity|November 10, 2018
Whatever happened to the Shwartzman phenomenon?Abdullah B Chahin, Jason M Opal, Steven M Opal
Critical Care Medicine|May 11, 2002
Antithrombin, heparin, and heparan sulfateSteven M Opal, Craig M Kessler, Juergen Roemisch, et al.
Plos One|February 18, 2016
Isolating Influenza RNA from Clinical Samples Using Microfluidic Oil-Water InterfacesFrancis R Cui, Jingjing Wang, Steven M Opal, et al.
Critical Care Medicine|March 11, 2003
Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemiaSteven M Opal, John E Palardy, Nicolas Parejo, et al.
Critical Care Medicine|April 24, 2008
Sepsis: time to reconsider the conceptJean Carlet, Jonathan Cohen, Thierry Calandra, et al.
Mbio|February 25, 2016
Reply to "Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?"David S Fedson, Jeffrey R Jacobson, Ole Martin Rordam, et al.
Lancet (London, England)|March 12, 2013
Sepsis definitions: time for changeJean-Louis Vincent, Steven M Opal, John C Marshall, et al.
Mbio|June 25, 2015
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor BlockersDavid S Fedson, Jeffrey R Jacobson, Ole Martin Rordam, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|October 7, 2014
Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodiesThomas T DeLeon, Heath H Chung, Steven M Opal, et al.
Pageof 17